WELLGISTICS HEALTH, INC.

WGRX

CIK 0002030763 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$2M
↓-86.5% -$11Mvs FY2024 (Q4)
Gross Profit
$0
↓-100.0% -$1Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
38/100
  • Profitability
    0ROIC -359.9% (10% = solid, 20%+ = moat)
  • Liquidity
    0Current Ratio 0.09 (above 1.5 = solid)
  • Leverage
    100D/E -1.89 (under 0.5 = conservative)
  • Efficiency
    26Asset Turnover 0.53x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -86.5% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -1047.1% · trend +189.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Stock-based comp (TTM)
$83M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$30M
everything owned
Total liabilities
$43M
everything owed
Stockholders' equity
$-12M
shareholder claim
Net debt
$23M
LT debt minus cash

Recent performance · 8 quarters

Revenue↓-86.5% -$11M
$2M
Net Income↓-1738.1% -$32M
$-34M
Free Cash Flow↓-4413.6% -$1M
$-1M
Operating Margin↓-1016.4pts
-1047.1%

Drill down